Anjelo Mida, Inc. Company Profile

13:39 EST 23rd November 2017 | BioPortfolio

Anjelo Mida, Inc. was established in 1998 as a pharmaceutical distributor providing fast and reliable medical products and services to the world. We have then expanded our line of products to vaccines, injectables, chemotherapy drugs, hospital drugs, and a variety of disposable medical products.We supply to physicians, pharmacies, clinics, university and colleges, and even hospitals. Our prices are very competitive in the U.S.A. with both generic and brand names. We can also offer asian and european pharmaceuticals for "export only" to any foreign individual or company. We specialize in researching "hard to find medicines" from around the world. Anjelo Mida, also provides one of the most complete lines of high quality chemicals for use in research and laboratories today. We will help you save money and time with your purchases of pharmaceuticals, chemicals and medical supplies


4617 Benson Avenue, Suite A
United States of America


Phone: 410-737-8449
Fax: 410-737-8450

News Articles [0 Results]


Drugs and Medications [0 Results]


PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Stereoselective Direct Chlorination of Alkenyl MIDA Boronates: Divergent Synthesis of E and Z- α-Chloro Alkenyl Boronates.

The individual molecules of α-chloro alkenyl boronates include both an electrophilic C-Cl bond and a nucleophilic C-B bond, which makes them intriguing organic synthons. Reported herein is a stereodi...

Theoretical study of the BF3-promoted rearrangement of oxiranyl N-methyliminodiacetic acid boronates.

The mechanism of the rearrangement of oxiranyl N-methyliminodiacetyl (MIDA) boronates has been extensively investigated with the density functional theory in dichloromethane. Several reaction pathways...

The lectin chaperone calnexin is involved in endoplasmic reticulum stress response by regulating Ca(2+) homeostasis in Aspergillus nidulans.

The Ca(2+)-mediated signaling pathway is crucial for environmental adaptation in fungi. Here we show that calnexin, a molecular chaperone located in the endoplasmic reticulum (ER), plays an important ...

The MIDA Mortality Risk Score: development and external validation of a prognostic model for early and late death in degenerative mitral regurgitation.

In degenerative mitral regurgitation (DMR), lack of mortality scores predicting death favours misperception of individual patients' risk and inappropriate decision-making.

Amphoteric Borylketenimines: Versatile Intermediates in the Synthesis of Borylated Heterocycles.

We report the first synthesis of amphoteric borylketenimines from ethynyl MIDA boronate and sulfonyl azides via copper catalysis. In situ trapping of these intermediates with various nucleophiles prov...

Clinical Trials [0 Results]


Companies [1 Associated Companies listed on BioPortfolio]

Anjelo Mida, Inc.

Anjelo Mida, Inc. was established in 1998 as a pharmaceutical distributor providing fast and reliable medical products and services to the world. We have then expanded our line of products to vaccines...

More Information about "Anjelo Mida, Inc." on BioPortfolio

We have published hundreds of Anjelo Mida, Inc. news stories on BioPortfolio along with dozens of Anjelo Mida, Inc. Clinical Trials and PubMed Articles about Anjelo Mida, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Anjelo Mida, Inc. Companies in our database. You can also find out about relevant Anjelo Mida, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Corporate Database Quicklinks

Searches Linking to this Company Record